Search Results 111-120 of 21250 for anti-TNF drugs

  1. Osteoporosis treatment: Medications can help - Mayo Clinic

    Find out more about your options for bone-preserving drugs, including how often you need to take them and what side effects you might expect.

  2. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

  3. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

  4. Blood Test Could Prevent Medication Trial and Error for Rheumatoid Arthritis Patients - Mayo Clinic News Network

    Researchers tested blood samples taken before rheumatoid arthritis treatment was given. The patients then were treated with anti-inflammatory biologic drugs ...

  5. Clinical Trials - Mayo Clinic Research

    ... Anti-TNF Therapy (Step-Up HS) A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With ...

  6. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

    ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

  7. NSAIDs: Do they increase my risk of heart attack and stroke? - Mayo Clinic

    Answer From Rekha Mankad, M.D.. Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) — medications commonly used to treat pain and inflammation — can increase the ...

  8. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

  9. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  10. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...